Sandoz Group (OTCMKTS:SDZNY) Hits New 12-Month High – Here’s What Happened

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) reached a new 52-week high during trading on Friday . The company traded as high as $63.72 and last traded at $63.72, with a volume of 369 shares changing hands. The stock had previously closed at $63.00.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group downgraded Sandoz Group from a “strong-buy” rating to a “hold” rating in a research report on Friday, August 8th. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Sandoz Group Stock Down 0.2%

The business has a 50-day moving average of $57.78 and a 200-day moving average of $49.50. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.24 and a quick ratio of 0.79.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.